498 results on '"Vokes, E. E."'
Search Results
2. Head and Neck Tumors
3. Non-Small Cell Lung Cancer
4. Kopf- und Halstumoren
5. Intensified concomitant chemoradiotherapy for poor prognosis head and neck cancer
6. Response-adapted volume de-escalation (RAVD) in locally advanced head and neck cancer
7. Pathways to improving combined modality therapy for stage III nonsmall-cell lung cancer
8. Phase II trial of dasatinib for recurrent or metastatic c-KIT expressing adenoid cystic carcinoma and for nonadenoid cystic malignant salivary tumors
9. Efficacy of concomitant chemoradiotherapy in poor prognosis head and neck cancer
10. 5-Fluorouracil modulation in head and neck cancer
11. Combined modality therapy for stage III non-small cell lung cancer : the University of Chicago experience
12. Comparison of outcomes of locoregionally advanced oropharyngeal and non-oropharyngeal squamous cell carcinoma over two decades
13. Induction chemotherapy, surgery and concomitant chemoradiotherapy for carcinoma of the esophagus
14. Concomitant chemoradiotherapy for solid tumors
15. A phase I dose escalation study of Ad GV.EGR.TNF.11D (TNFerade™ Biologic) with concurrent chemoradiotherapy in patients with recurrent head and neck cancer undergoing reirradiation
16. Evidence-based role of bevacizumab in non-small cell lung cancer
17. UGT1A1*28 polymorphism as a determinant of irinotecan disposition and toxicity
18. THE ROLE OF ANTI-EPIDERMAL GROWTH FACTOR RECEPTOR ANTIBODIES IN HEAD AND NECK CANCER
19. Phase II trial of pemetrexed-based induction chemotherapy followed by concomitant chemoradiotherapy in previously irradiated patients with squamous cell carcinoma of the head and neck
20. A randomized phase II study of 5-fluorouracil, hydroxyurea, and twice-daily radiotherapy compared with bevacizumab plus 5-fluorouracil, hydroxyurea, and twice-daily radiotherapy for intermediate-stage and T4N0-1 head and neck cancers
21. Induction chemotherapy and concurrent chemoradiotherapy for locoregionally advanced head and neck cancer: a multi-institutional phase II trial investigating three radiotherapy dose levels
22. Functional organ preservation with definitive chemoradiotherapy for T4 laryngeal squamous cell carcinoma
23. RATIONALE 001: Tislelizumab (BGB-A317) 1 concurrent chemoradiotherapy (cCRT) followed by tislelizumab monotherapy in patients (pts) with newly diagnosed locally advanced, unresectable, stage III non-small cell lung cancer (NSCLC)
24. A phase I trial of concomitant chemoradiotherapy with cisplatin dose intensification and granulocyte-colony stimulating factor support for advanced malignancies of the chest
25. Phase II trial of oxaliplatin, leucovorin and fluorouracil in patients with advanced carcinoma of the esophagus
26. Patterns of failure, prognostic factors and survival in locoregionally advanced head and neck cancer treated with concomitant chemoradiotherapy: a 9-year, 337-patient, multi-institutional experience
27. Preliminary Results of Radiation Therapy Oncology Group 97-03: A Randomized Phase II Trial of Concurrent Radiation and Chemotherapy for Advanced Squamous Cell Carcinomas of the Head and Neck
28. A phase II study of oxaliplatin and paclitaxel in patients with advanced non-small-cell lung cancer
29. A phase II trial of the epothilone B analog, BMS-247550, in patients with previously treated advanced colorectal cancer
30. With regard to “Induction chemotherapy followed by concomitant chemoradiotherapy in the treatment of locoregionally advanced nasopharyngeal cancer” by Oh et al. (AnnOnc 2003; 14: 464–569)
31. Non-Small-Cell Lung Cancer
32. Carcinoma of the Esophagus
33. Multimodality Therapy
34. Phase-II study of oxaliplatin in patients with inoperable, locally advanced or metastatic transitional cell carcinoma of the urothelial tract (TCC) who have received prior chemotherapy: 1638
35. Phase II study of flavopiridol in patients with advanced colorectal cancer
36. Concurrent chemoradiotherapy for N2 or N3 squamous cell carcinoma of the head and neck from an occult primary
37. Phase I/II investigation of paclitaxel, ifosfamide and carboplatin for advanced non-small-cell lung cancer
38. A case study documenting the anticancer activity of ZD1839 (Iressa) in the brain
39. Induction chemotherapy followed by concomitant chemoradiotherapy in the treatment of locoregionally advanced nasopharyngeal cancer
40. A pilot trial of G3139, a bcl-2 antisense oligonucleotide, and paclitaxel in patients with chemorefractory small-cell lung cancer
41. Phase-II-Studie mit Oxaliplatin (OXA) und Paclitaxel (PA) beim fortgeschrittenen nichtkleinzelligen Lungenkarzinom (NSCLC): 2852
42. Phase-II-Studie zu Oxaliplatin (OXA), 5-Fluorouracil (5-FU) und Leucovorin (FA) bei metastasierendem Ösophagus-Kardia-Karzinom: 650
43. Phase II studies of bryostatin-1 in patients with advanced sarcoma and advanced head and neck cancer
44. Sequential induction chemotherapy and concomitant chemoradiotherapy in the management of locoregionally advanced laryngeal cancer
45. A phase I-II study of concomitant chemoradiotherapy with paclitaxel (one-hour infusion), 5-fluorouracil and hydroxyurea with granulocyte colony stimulating factor support for patients with poor prognosis head and neck cancer
46. Pharmacokinetic-Pharmacodynamic (PK-PD) Analysis of Intestinal Toxicity Associated with Irinotecan (CPT-11): Validation of Biliary Index (BI): PIII-38
47. Should non-small cell carcinoma of the lung be treated with chemotherapy? Pro: chemotherapy is for non-small cell lung cancer.
48. Nivolumab Versus Investigator'S Choice (IC) for Platinum-Refractory Recurrent or Metastatic (R/M) Squamous Cell Carcinoma of the Head and Neck (SCCHN; CHECKMATE 141) : Outcomes in First-Line R/M Patients and Updated Safety and Efficacy
49. Nivolumab versus docetaxel in previously treated advanced non-small-cell lung cancer (CheckMate 017 and CheckMate 057): 3-year update and outcomes in patients with liver metastases.
50. Sorafenib (SOR) in patients (pts) with imatinib (IM) and sunitinib (SU)-resistant (RES) gastrointestinal stromal tumors (GIST): Final results of a University of Chicago Phase II Consortium trial.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.